Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patients
- PMID: 11205229
Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patients
Abstract
Alterations in cell cycle regulating proteins are common in many cancer types. Recent data suggest a possible link between CDC25 phosphatases overexpression and malignancy. Our objective was to evaluate the expression of the three cell cycle-related phosphatases CDC25A, CDC25B and CDC25C in patients with ovarian cancer. All the patients had a minimal follow up of three years. CDC25A, CDC25B and CDC25C expression were investigated by immunohistochemistry in 106 patients with ovarian cancer. CDC25A and CDC25B were found expressed in almost all the samples analyzed, while CDC25C was undetectable in more than 80% of the patients. The low evaluable data on CDC25C expression, did not allow any association between the expression of this phosphatase and prognosis. The expression of CDC25A and CDC25B showed some evidences of association with a poor prognosis (p = 0.034 and p = 0.058 respectively). This relationship was independent of other factors such as tumor grade, histotype, stage and residual tumor after surgery. In the same patients the examined parameters (residual tumor, grade, stage and histotype) did show the expected relation with survival. The results indicate that high CDC25A and CDC25B expression is related to a worse prognosis in ovarian cancer patients. CDC25 phosphatases expression can be regarded as a possible prognostic factor for ovarian cancer and these proteins should be evaluated as potential molecular _targets of novel drugs against this human neoplasm.
Similar articles
-
[Clinical characteristics and prognosis of epithelial ovarian cancer in young women].Ai Zheng. 2008 Sep;27(9):951-5. Ai Zheng. 2008. PMID: 18799034 Chinese.
-
Expression of cdc25A and cdc25B phosphatase in breast carcinoma.Breast Cancer. 2004;11(3):295-300. doi: 10.1007/BF02984552. Breast Cancer. 2004. PMID: 15550849
-
Overexpression of CDC25A phosphatase is associated with hypergrowth activity and poor prognosis of human hepatocellular carcinomas.Clin Cancer Res. 2003 May;9(5):1764-72. Clin Cancer Res. 2003. PMID: 12738732
-
[Prognostic factors of ovarian cancer].Gan To Kagaku Ryoho. 2006 Dec;33(13):2014-9. Gan To Kagaku Ryoho. 2006. PMID: 17197745 Review. Japanese.
-
Cell cycle control by the CDC25 phosphatases.Anticancer Agents Med Chem. 2008 Dec;8(8):818-24. doi: 10.2174/187152008786847756. Anticancer Agents Med Chem. 2008. PMID: 19075563 Review.
Cited by
-
Phosphatases and kinases regulating CDC25 activity in the cell cycle: clinical implications of CDC25 overexpression and potential treatment strategies.Mol Cell Biochem. 2016 May;416(1-2):33-46. doi: 10.1007/s11010-016-2693-2. Epub 2016 Apr 2. Mol Cell Biochem. 2016. PMID: 27038604 Free PMC article. Review.
-
Overexpression of Cyclin E1 or Cdc25A leads to replication stress, mitotic aberrancies, and increased sensitivity to replication checkpoint inhibitors.Oncogenesis. 2020 Oct 7;9(10):88. doi: 10.1038/s41389-020-00270-2. Oncogenesis. 2020. PMID: 33028815 Free PMC article.
-
Prognostic significance of CDC25B expression in gliomas.J Clin Pathol. 2006 Jul;59(7):725-8. doi: 10.1136/jcp.2005.029546. J Clin Pathol. 2006. PMID: 16803948 Free PMC article.
-
Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk.medRxiv [Preprint]. 2024 Mar 4:2024.02.29.24303243. doi: 10.1101/2024.02.29.24303243. medRxiv. 2024. PMID: 38496424 Free PMC article. Preprint.
-
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.J Exp Clin Cancer Res. 2017 May 8;36(1):63. doi: 10.1186/s13046-017-0536-y. J Exp Clin Cancer Res. 2017. PMID: 28482906 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous